The Icos Alumni: Where Are They Now?

Ardelle Dennis, executive assistant, CMC Icos

Mike Dennis, pharmaceuticals professional

Frank Diaz, assistant professor, University of North Alabama

Ken Dick, senior field technical specialist, LI-COR Biosciences

Greg Dietsch, vice president of research, VentiRx Pharmaceuticals

Tressa Dodd, senior director of regulatory affairs, VentiRx Pharmaceuticals

Jason Douangpanya, senior associate scientist, Amgen

Heather Douangpanya, senior associate scientist, Amgen

Tom Dudler, senior group leader, Omeros

Christian Eckhoff, senior scientist at SNBL USA

Ana Edwards, senior quality control analyst, Seattle Genetics

Kevin Egan, vice president of business development, CMC Icos

Fred Elliott, chemist, Bio-Rad Laboratories

Leslie Elliott, clinical research consultant

Nancy Enselman, office manager, VentiRx Pharmaceuticals

Angela Epp, research technologist III, Puget Sound Blood Center

James Esselstyn, production supervisor, Bio-Rad Laboratories

Jerry Evarts, principal scientist, chemistry, Calistoga Pharmaceuticals

Russell Eyre, director of safety assessment, SNBL USA

Gay Fanning, marketing assistant

Brian Farnes, safety coordinator, Nintendo

Rebekah Farnsworth, senior manager of technology transfer, Alder Biopharmaceuticals

Francine Farouz, senior director of medicinal chemistry, Fate Therapeutics

Valerie Fauvelle, associate manager of regulatory affairs, Gilead Sciences

Dave Federighi, senior analytical chemist, WIL Research Laboratories

Ken Ferguson, president and CEO, Imvaxyn

Gail Ferrari, executive assistant, business development, PopCap Games

Lacy Fitzpatrick, senior investor relations analyst, Nordstrom

Tim Fitzpatrick, site manager, Saltigo Redmond

Vince Florio, director of science, Omeros

Stephanie Florio, senior scientist, Infectious Disease Research Institute

Author: Luke Timmerman

Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.